Novel GPR40 superagonist demonstrates remarkable preclinical efficacy in models of diabetes Feb. 4, 2019
FDA approves sNDA to add moderate to severe vaginal dryness to the indication of Osphena Jan. 31, 2019
Orphazyme releases full data from phase II/III study of arimoclomol in Niemann-Pick disease type C Jan. 30, 2019
Novo Nordisk initiates phase I pharmacokinetic study of NNC0148-0287sema in type 2 diabetes Jan. 28, 2019
Alnylam initiates phase III trial of vutrisiran in hereditary transthyretin amyloidosis Jan. 25, 2019
RSS